Jacques Fellay receives the National Latsis Prize 2012
Recognition for researcher and clinician
On 10 January 2013, Jacques Fellay will receive the National Latsis Prize 2012 at the Rathaus in Berne. The Swiss National Science Foundation (SNSF) is awarding the Prize to the SNSF-funded professor at EPF Lausanne in recognition of his work on the human genome and its defence mechanisms against viral diseases such as AIDS. The National Latsis Prize is awarded to researchers of up to 40 years of age and is one of the most prestigious prizes in Switzerland.
Jacques Fellay feels just as much at home in basic research as in medical practice. To the doctor cum researcher, it is self-evident that progress in medicine requires an exchange between these two spheres. His research focuses on the interface between genomics and infectious diseases and shows that the information stored in our genes can be used to treat viral diseases such as AIDS.
At the beginning of this millennium, HIV therapies still had serious, undesired side-effects. Due to their genetic make-up, some patients have a higher concentration of drugs in the blood than others. This increases the risk of a toxic reaction. Knowledge of their genetic profile now makes it easier to predict harmful effects and adjust the treatment accordingly. Jacques Fellay has also identified variants of three genes that enable their carriers to exercise better immune control over the disease – perhaps a decisive step towards the development of a vaccine.
Having studied medicine at the University of Lausanne and done research at Duke University in the USA, Jacques Fellay now runs his own lab as an SNSF-funded professor at the School of Life Sciences of EPF Lausanne. Here, he and his team are also investigating why some children suffering from seasonal flu only have fever for a few days while others need to be admitted to the intensive care unit of a hospital.
The prize ceremony will be held on 10 January 2013 at the Rathaus, Rathausplatz 2 in Berne. There will amongst others be speeches by Federal Councillor Johann Schneider-Ammann, Head of the Federal Department of Economic Affairs, Education and Research; Prof. Martin Vetterli, President of the National Research Council of the SNSF and Andreas Rickenbacher, President of the Cantonal Council of the Canton of Bern.
Representatives of the media are invited to attend the prize ceremony. Please contact the Communication division of the SNSF (email@example.com or tel. 031 308 23 87).
Prizes of the Latsis Foundation
The Latsis Foundation was established by the Greek family Latsis in Geneva in 1975. The National Latsis Prize is awarded by the Swiss National Science Foundation on behalf of the Latsis Foundation. In addition, there are four university Latsis prizes worth 25,000 Swiss francs each, which are awarded by the University of Geneva, the University of St. Gallen, ETH Zurich and EPF Lausanne respectively.
Contact details of the laureate
Prof. Jacques Fellay
Global Health Institute
School of Life Sciences
Tel.: +41 21 693 18 49
Abteilung Kommunikation | idw
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
Personal patches could reduce energy waste in buildings, Rutgers-led study says
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Key advance for future topological transistors
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...